Metaclopramide and Prolactin

Wilson, Ronald G.
August 1974
British Medical Journal;8/10/1974, Vol. 3 Issue 5927, p413
Academic Journal
No abstract available.


Related Articles

  • Metoclopramide.  // Reactions Weekly;11/1/2008, Issue 1226, p19 

    The article describes the case of a 71-year-old man with Parkinson's disease (PD) who developed encephalopathy after beginning treatment with metaclopramide. After starting metaclopramide, he experienced a marked exacerbation of his motor symptomology, agitation, aggression and changes in...

  • FDA Actions.  // Critical Care Alert;May2009 Pharmacology Watch, p2 

    The article reports on the requirement of the U.S. Food and Drug Administration (FDA) on manufacturers of metaclopramide to include a box warning concerning the risk of long term or high-dose use and tardive duskinesia in their labeling.

  • Metoclopramide/ondansetron.  // Reactions Weekly;4/17/2010, Issue 1297, p36 

    The article describes the case of a 56-year-old woman who developed acute dystonia while being treated with ondansetron and metaclopramide for low-grade non-Hodgkin lymphoma.

  • Prolactin: Physiology and Clinical Significance/Prolactin 1974 (Book).  // Annals of Internal Medicine;Nov75, Vol. 83 Issue 5, p748 

    Reviews two books about prolactin. 'Prolactin: Physiology and Clinical Significance' and 'Prolactin 1974,' by David F. Horrobin.

  • Serum prolactin in epilepsy and hysteria. Trimble, Michael R. // British Medical Journal;12/16/1978, Vol. 2 Issue 6153, p1682 

    Investigates the prolactin release during epilepsy and hysteria. Mechanism of prolactin release during seizure; Role of basal hypothalamus in prolactin release; Difference between epilepsy and hysteria.

  • Raised Serum Prolactin Levels in Amenorrhoea. Seppälä, M.; Hirvonen, E.; Ranta, T.; Virkkunen, P.; Leppäluoto, J. // British Medical Journal;5/10/1975, Vol. 2 Issue 5966, p305 

    Examines the raised serum prolactin levels in Amenorrhoea. Measurement of serum prolactin levels by specific radio immunoassay; Relationship between serum prolactin levels and levels of follicle-stimulating hormone; Transient fall of in the prolactin levels.

  • Influence of age on serum prolactin levels in women and men. Vekemans, M.; Robyn, C. // British Medical Journal;12/27/1975, Vol. 4 Issue 5999, p738 

    Investigates the influence of age on serum prolactin levels in women and men. Reduction of serum prolactin levels at menopause; Increase of serum prolactin levels with increasing age in men; Role of estrogen in the regulation of prolactin secretions.

  • SHIRES' OPTION FOR RIGHTS TO EMITASOL EXPIRES.  // Worldwide Biotech;Dec2001, Vol. 13 Issue 12, p1 

    Reports the expiration of Shire Pharmaceuticals Group's option to acquire the exclusive rights to market the intranasal metaclopramide Emitasol from Questcor Pharmaceuticals Inc. in North America. Information on emitasol and emesis; Views of the American Cancer Society on the drug; Details on...

  • PREDICTION, PROPHYLAXIS AND TREATMENT OF PONV. Jakobsson, Jan G. // Ambulatory Surgery;Apr2007 Supplement, Vol. 13, p99 

    The article presents the factors contributing to the causation of postoperative nausea and vomiting (PONV) as well as its treatment and prevention. It is remarkable that PONV is one of the most frequent and problematic adverse effect of ambulatory surgery resulting into greater problems and...

  • Development of pituitary adenoma in women with hyperprolactinaemia: clinical, endocrine, and radiological characteristics. Pontiroli, Antonio E.; Falsetti, Leopoldo // British Medical Journal (Clinical Research Edition);2/18/1984, Vol. 288 Issue 6416, p515 

    Investigates pituitary adenoma in women with hyperprolactinemia. Clinical course of the disease; Elevation of serum prolactin concentrations; Significance of the tests for the release of prolactin.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics